Previous close | 0.3380 |
Open | 0.3380 |
Bid | 0.2900 x N/A |
Ask | 0.3920 x N/A |
Day's range | 0.3380 - 0.3420 |
52-week range | 0.1530 - 0.3620 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
While hVIVO plc ( LON:HVO ) might not have the largest market cap around , it led the AIM gainers with a relatively...
Key Insights The projected fair value for hVIVO is UK£0.37 based on 2 Stage Free Cash Flow to Equity hVIVO is estimated...
Drugmakers are in a race to develop vaccines and drugs to treat respiratory diseases caused by respiratory syncytial virus and COVID-19, resulting in increased demand for clinical testing of the products. The contract research organisation now expects its annual revenue to be 55 million pounds ($68.8 million), compared with 53 million pounds it previously expected.